PNPLA6 p.Val61Leu

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong

The NM_001166114.2(PNPLA6):​c.181G>T​(p.Val61Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. V61V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PNPLA6
NM_001166114.2 missense

Scores

18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0250

Publications

0 publications found
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
PNPLA6 Gene-Disease associations (from GenCC):
  • ataxia-hypogonadism-choroidal dystrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • PNPLA6-related spastic paraplegia with or without ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 39
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebellar ataxia-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Laurence-Moon syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichomegaly-retina pigmentary degeneration-dwarfism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001166114.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the PNPLA6 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 29 curated pathogenic missense variants (we use a threshold of 10). The gene has 7 curated benign missense variants. Gene score misZ: 4.3547 (above the threshold of 3.09). Trascript score misZ: 3.5139 (above the threshold of 3.09). GenCC associations: The gene is linked to PNPLA6-related spastic paraplegia with or without ataxia, ataxia-hypogonadism-choroidal dystrophy syndrome, hereditary spastic paraplegia 39, trichomegaly-retina pigmentary degeneration-dwarfism syndrome, retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome, Laurence-Moon syndrome, cerebellar ataxia-hypogonadism syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.05587101).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166114.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
NM_001166114.2
MANE Select
c.181G>Tp.Val61Leu
missense
Exon 1 of 32NP_001159586.1A0A384DVU0
PNPLA6
NM_001166111.2
c.208G>Tp.Val70Leu
missense
Exon 3 of 34NP_001159583.1Q8IY17-4
PNPLA6
NM_001166113.1
c.64G>Tp.Val22Leu
missense
Exon 4 of 35NP_001159585.1Q8IY17-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
ENST00000600737.6
TSL:1 MANE Select
c.181G>Tp.Val61Leu
missense
Exon 1 of 32ENSP00000473211.1A0A384DVU0
PNPLA6
ENST00000221249.10
TSL:1
c.64G>Tp.Val22Leu
missense
Exon 4 of 35ENSP00000221249.5Q8IY17-2
PNPLA6
ENST00000450331.7
TSL:1
c.64G>Tp.Val22Leu
missense
Exon 4 of 35ENSP00000394348.2Q8IY17-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1430540
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
709466
African (AFR)
AF:
0.00
AC:
0
AN:
33300
American (AMR)
AF:
0.00
AC:
0
AN:
39956
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25538
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82642
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46346
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5646
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1099112
Other (OTH)
AF:
0.00
AC:
0
AN:
59322
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.8
DANN
Benign
0.84
DEOGEN2
Benign
0.0090
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.056
T
MetaSVM
Benign
-0.90
T
PhyloP100
-0.025
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.15
N
REVEL
Benign
0.032
Sift
Benign
1.0
T
Sift4G
Benign
0.65
T
PromoterAI
0.017
Neutral
Varity_R
0.038
gMVP
0.48
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr19-7600855;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.